Education
About Us
Working with TipRanks
Follow Us
Japan Tobacco Inc. (JP:2914)
:2914
2914 Stock Chart & Stats
¥5980.00
-¥67.00(-1.67%)
At close: 4:00 PM EST
¥5980.00
-¥67.00(-1.67%)
Day’s Range― - ―
52-Week Range¥3,761.00 - ¥6,182.00
Previous CloseN/A
Volume9.18M
Average Volume (3M)3.98M
Market Cap
¥10.59T
Enterprise Value¥11.44T
Total Cash (Recent Filing)¥831.13B
Total Debt (Recent Filing)¥1.68T
Price to Earnings (P/E)19.6
Beta0.52
Next Earnings
May 08, 2026EPS Estimate
90.29Next Dividend Ex-DateN/A
Dividend Yield3.49%
Share Statistics
EPS (TTM)-0.88
Shares Outstanding2,000,000,000
10 Day Avg. Volume4,011,180
30 Day Avg. Volume3,977,306
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)2.45
Price to Sales (P/S)2.89
P/FCF Ratio27.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥6,450.00Price Target Upside7.86% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)347.81
Revenue Forecast (FY)¥3.70T
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthConsistent top-line growth across 2020–2025 indicates enduring demand for JT’s core products and effective pricing/market strategies. A steady revenue base supports reinvestment, long-term cash flow generation and strategic initiatives in pharmaceuticals and foods, enhancing resilience versus single-year shocks.
Consistent Cash GenerationRepeated positive operating and free cash flow provides durable internal funding for dividends, capex and targeted R&D or M&A. Reliable cash conversion underpins financial flexibility, helps service debt, and supports long-term capital allocation even amid cyclical variations in earnings.
Diversified Consumer & Pharma MixA tobacco franchise plus pharmaceuticals and processed foods spreads revenue risk and creates multiple cash-generating channels. Global distribution and local country operations allow scale, portfolio balancing and cross-market resilience to region-specific demand or regulatory shifts, strengthening long-term stability.
Bears Say
Rising LeverageA meaningful step-up in debt in 2024–2025 raises refinancing, interest and covenant risk and reduces maneuverability for capital allocation. Higher leverage can constrain investment in growth or R&D, pressure ratings, and amplify downside in a revenue or cash-flow slowdown, affecting multi‑quarter resilience.
Volatile Profit & Cash ConversionIrregular profit and free-cash-flow conversion reduces predictability of distributable cash and investment capacity. This variability complicates forecasting, capital budgeting and debt reduction plans, and may force more conservative financial policies that limit growth investments over the medium term.
Regulatory And Tax ExposureStructural exposure to excise taxes and tightening regulation can erode volume and margin over time, forcing price adjustments or reduced sales. Persistent regulatory headwinds create a durable revenue and margin risk that demands ongoing product, pricing and market diversification strategies to sustain long-term earnings.
Japan Tobacco News
2914 FAQ
What was Japan Tobacco Inc.’s price range in the past 12 months?
Japan Tobacco Inc. lowest stock price was ¥3761.00 and its highest was ¥6182.00 in the past 12 months.
What is Japan Tobacco Inc.’s market cap?
Japan Tobacco Inc.’s market cap is ¥10.59T.
When is Japan Tobacco Inc.’s upcoming earnings report date?
Japan Tobacco Inc.’s upcoming earnings report date is May 08, 2026 which is in 50 days.
How were Japan Tobacco Inc.’s earnings last quarter?
Japan Tobacco Inc. released its earnings results on Feb 12, 2026. The company reported -¥0.88 earnings per share for the quarter, missing the consensus estimate of ¥34.932 by -¥35.812.
Is Japan Tobacco Inc. overvalued?
According to Wall Street analysts Japan Tobacco Inc.’s price is currently Undervalued.
Does Japan Tobacco Inc. pay dividends?
Japan Tobacco Inc. pays a Semiannually dividend of ¥130 which represents an annual dividend yield of 3.49%. See more information on Japan Tobacco Inc. dividends here
What is Japan Tobacco Inc.’s EPS estimate?
Japan Tobacco Inc.’s EPS estimate is 90.29.
How many shares outstanding does Japan Tobacco Inc. have?
Japan Tobacco Inc. has 2,000,000,000 shares outstanding.
What happened to Japan Tobacco Inc.’s price movement after its last earnings report?
Japan Tobacco Inc. reported an EPS of -¥0.88 in its last earnings report, missing expectations of ¥34.932. Following the earnings report the stock price went up 1.572%.
Which hedge fund is a major shareholder of Japan Tobacco Inc.?
Currently, no hedge funds are holding shares in JP:2914
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Tobacco Inc.
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
2914 Company Deck
2914 Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong financial performance in the tobacco segment, driven by organic growth and the successful acquisition of the Vector Group. Revised upward forecasts and dividend increases further highlight positive momentum. However, challenges persist with negative FX impacts, processed food business decline, and potential risks in key markets like Russia and Turkey.View all JP:2914 earnings summaries2914 Stock 12 Month Forecast
Average Price Target
¥6,450.00
▲(7.86% Upside)
Technical Analysis
Asahi Group Holdings
―
Kirin Holdings Company
―
Sapporo Holdings
―
Suntory Beverage & Food
―
Takara Holdings Inc.
―
Options Prices
Currently, No data available
---